Cita APA (7a ed.)

Pérez Alba, E., Nuzzolo Shihadeh, L. M., Aguirre García, G. M., Espinosa Mora, J. E., Lecona García, J. D., Flores Pérez, R. O., . . . Camacho Ortiz, A. (2021). Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis. Scientific Communications International.

Cita Chicago Style (17a ed.)

Pérez Alba, Eduardo, Laura Marina Nuzzolo Shihadeh, Gloria Mayela Aguirre García, Jaime Eugenio Espinosa Mora, Juan Diego Lecona García, Rómulo Omar Flores Pérez, Marisela Mendoza Garza, y Adrián Camacho Ortiz. Baricitinib Plus Dexamethasone Compared to Dexamethasone for the Treatment of Severe COVID-19 Pneumonia: A Retrospective Analysis. Scientific Communications International, 2021.

Cita MLA (9a ed.)

Pérez Alba, Eduardo, et al. Baricitinib Plus Dexamethasone Compared to Dexamethasone for the Treatment of Severe COVID-19 Pneumonia: A Retrospective Analysis. Scientific Communications International, 2021.

Precaución: Estas citas no son 100% exactas.